PHASE II STUDY OF CARBOPLATIN-DOCETAXEL-BEVACIZUMAB AS FRONT-LINE TREATMENT IN PATIENTS WITH STAGE IV NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER. ANALYSIS OF THE BEVACIZUMAB (BVZ) MAINTENANCE POPULATION

JOURNAL OF THORACIC ONCOLOGY(2013)

Cited 0|Views6
No score
Key words
metastatic,Bevacizumab,Maintenance treatment,Non squamous NSCLC
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined